Cell-Based Immunotherapy: The Evolving Blood Cancer Treatment Market
The management of hematological malignancies has been transformed by advances in cell-based immunotherapy, with CAR-T therapy emerging as a key treatment modality. Cell-based immunotherapy harnesses the power of the immune system to fight cancer, offering personalized treatment with the potential for durable remissions. The CAR T therapy in haematological malignancy market is...
0 Σχόλια 0 Μοιράστηκε 5 Views 0 Προεπισκόπηση